Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TREH | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZC3H15 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CNPY1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | KMT2E | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | FOXD2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RP11-552F3.12 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | C11orf65 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | DPM3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RELB | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | KRTAP21-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |